All Wellness Tests

The Bilirubin Direct Test measures conjugated bilirubin in the blood to assess liver function and bile duct health. Elevated levels may indicate hepatitis, cirrhosis, gallstones, or bile duct obstruction, while low levels are generally normal. Doctors order this test for patients with jaundice, fatigue, or suspected liver disease. Results help diagnose and monitor liver disorders, guide treatment decisions, and evaluate overall hepatic and biliary health.

The C-Reactive Protein (CRP) Test measures CRP levels in blood to detect inflammation in the body. Elevated CRP may indicate infections, autoimmune disorders, or chronic diseases such as arthritis, cardiovascular disease, or inflammatory bowel disease. Doctors use this test to assess acute illness, monitor treatment response, and evaluate risk for heart disease. The CRP test provides key insight into inflammation, immune health, and overall wellness.

The High-Sensitivity C-Reactive Protein (hs-CRP) Test measures very low levels of CRP in blood to evaluate inflammation and cardiovascular risk. Elevated hs-CRP may indicate increased risk for heart disease, heart attack, or stroke even before symptoms appear. Doctors use this test along with cholesterol and other markers to assess overall heart health, guide prevention strategies, and monitor treatment. It also helps evaluate chronic inflammation and metabolic conditions.

The CA 125 Test measures the level of cancer antigen 125 in blood, a protein often elevated in ovarian cancer and some other conditions. While not used alone for diagnosis, it helps monitor treatment effectiveness, detect recurrence, or assess disease progression. Elevated CA 125 may also be seen in endometriosis, fibroids, or pelvic inflammation. Doctors use this test to support cancer management and track overall reproductive and abdominal health.

The CA 15-3 Test measures cancer antigen 15-3 levels in blood, often used to monitor breast cancer treatment and progression. Elevated levels may suggest advanced breast cancer, metastasis, or recurrence, while non-cancer conditions can also affect results. Doctors order this test alongside imaging and other labs to track therapy response or detect changes in disease status. Results help guide ongoing management of breast cancer and patient care.

The CA 19-9 Test measures levels of carbohydrate antigen 19-9 in blood, a tumor marker often elevated in pancreatic cancer and sometimes in bile duct, colorectal, or liver cancers. While not used alone for diagnosis, it helps monitor treatment, track disease progression, and detect recurrence. Elevated CA 19-9 may also occur in noncancerous conditions. Doctors use this test to support cancer management and guide therapy decisions.

The CA 27.29 Test measures cancer antigen 27.29 levels in blood to help monitor breast cancer treatment, progression, or recurrence. Elevated levels may indicate advanced or metastatic breast cancer, though non-cancer conditions can also affect results. Doctors order this test alongside imaging or other tumor markers to track therapy response. Results provide valuable insight for ongoing breast cancer management and long-term patient care.

The Calcium Micronutrient Test measures calcium levels in the blood to assess nutritional status and detect imbalances. Calcium is essential for strong bones and teeth, muscle contraction, nerve signaling, and heart function. This test helps identify deficiencies, excess, or issues with absorption and metabolism, supporting diagnosis and management of bone health, hormonal balance, and overall wellness.

Patient must be 18 years of age or older.

The Calcium Test measures calcium levels in blood to assess bone health, parathyroid function, and metabolic balance. Abnormal levels may indicate bone disease, parathyroid disorders, kidney disease, or certain cancers. Both low and high calcium can cause muscle spasms, weakness, or irregular heartbeat. Doctors order this test to monitor osteoporosis, kidney stones, or endocrine disorders. Results provide essential insight into bone, nerve, and overall metabolic health.

The Heavy Metals Micronutrients Blood Test Panel measures levels of arsenic, cadmium, cobalt, lead, and mercury to assess exposure and potential toxicity. These metals, found in the environment, food, or workplaces, can affect the nervous system, kidneys, bones, and overall health. This panel helps detect harmful accumulation, guide treatment, and monitor risks from environmental or occupational exposure.

Patient must be 18 years of age or older.

The Cardio IQ™ ApoE Genotype Test analyzes apolipoprotein E (ApoE) gene variants linked to cholesterol metabolism and cardiovascular risk. Results help assess risk for heart disease, hyperlipidemia, and Alzheimer’s disease. This genetic test guides personalized prevention and treatment strategies, including diet, lifestyle, and lipid-lowering therapies, supporting long-term cardiovascular and brain health.

The Cardio IQ™ Lipoprotein Fractionation Ion Mobility Test separates and measures lipoprotein particles by size and concentration using ion mobility technology. It provides a detailed profile of LDL, HDL, and other subclasses, offering a clearer assessment of cardiovascular risk than standard cholesterol testing.

The NMR Lipoprotein Fractionation Test uses nuclear magnetic resonance to measure particle size and concentration of LDL, HDL, and VLDL cholesterol. Unlike a standard lipid panel, it provides detailed information on lipoprotein subfractions linked to cardiovascular risk. Doctors use this test to assess heart disease risk, guide cholesterol management, and monitor therapy effectiveness. It offers deeper insight into lipid metabolism and cardiovascular health.

The Carotene Test measures blood carotene levels to evaluate vitamin A status, dietary intake, and fat absorption. Carotene, a precursor of vitamin A, is essential for vision, immune function, and skin health. Abnormal levels may indicate malnutrition, fat malabsorption, or liver disease. Physicians use this test to assess nutritional health, monitor absorption disorders, and support diagnosis of conditions affecting metabolism and overall wellness.

The CBC with H/H, RBC, Indices, WBC and Platelets Test evaluates overall blood health by measuring hemoglobin, hematocrit, red blood cell count, size and indices, white blood cell levels, and platelets. It helps detect anemia, infections, clotting disorders, and immune or bone marrow conditions. Frequently ordered in routine exams, this test supports diagnosis, monitoring of chronic disease, and assessment of general health.

The CEA Test measures carcinoembryonic antigen levels in blood, a protein that may be elevated in certain cancers, especially colorectal, pancreatic, lung, breast, or ovarian cancer. It is not used alone for diagnosis but helps monitor cancer treatment, detect recurrence, and track disease progression. Elevated CEA can also occur in noncancerous conditions. Doctors use this test to support therapy decisions and provide insight into cancer management.

The Ceruloplasmin Test measures levels of ceruloplasmin, a copper-carrying protein made in the liver, to evaluate copper metabolism and related disorders. Low levels may indicate Wilson’s disease, Menkes disease, or severe liver disease, while high levels may suggest inflammation or pregnancy. Doctors order this test for patients with liver problems, neurological symptoms, or abnormal copper levels. Results help diagnose metabolic disorders and guide treatment.

The Complete Blood Count with Differential and Platelets Test is a comprehensive blood test that checks red blood cells, white blood cells, hemoglobin, hematocrit, and platelets. The differential analyzes types of white blood cells to detect infections, anemia, clotting abnormalities, immune conditions, and certain cancers. This essential test is often ordered for routine health exams, diagnosis, and monitoring treatment progress.

The Comprehensive Metabolic Panel (CMP) Test measures 21 markers to assess metabolic health, liver and kidney function, and electrolyte balance. It includes glucose, calcium, sodium, potassium, chloride, CO2, albumin, globulin, A/G ratio, total protein, bilirubin, ALP, AST, ALT, BUN, creatinine, BUN/creatinine ratio, and eGFR. The CMP helps detect diabetes, liver or kidney disease, and supports routine screening and chronic condition monitoring.

 The Comprehensive Wellness Profile (CWP) is a broad health screening tool that encompasses several key tests to evaluate overall health, organ function, and risk factors for various diseases. This profile includes a Complete Blood Count with Differential and Platelets, Comprehensive Metabolic Panel (CMP), Total Iron, Lipid Panel with Ratios, and Thyroid Stimulating Hormone (TSH) test. This combination provides a detailed look at blood health, metabolic function, thyroid activity, iron levels, and cardiovascular risk.

 The Comprehensive Wellness Profile (CWP) + Vit D is an expanded health screening panel that combines a broad spectrum of tests to assess overall health, organ function, and nutritional status. This panel includes a Complete Blood Count with Differential and Platelets, Comprehensive Metabolic Panel, Total Iron, Lipid Panel with Ratios, Thyroid Stimulating Hormone, and a specific test for Vitamin D levels (QuestAssureD 25-Hydroxyvitamin D Total with D2 and D3). It's designed to give a holistic view of an individual's health, from blood cell health and metabolic function to cardiovascular risk, thyroid function, and vitamin D status.

The Copper Micronutrient Plasma Test measures copper levels in the blood to evaluate nutritional status and detect deficiencies or excess. Copper is essential for red blood cell formation, connective tissue health, energy production, and nervous and immune system function. This test helps identify imbalances from poor diet, malabsorption, or toxicity, supporting diagnosis and management of overall health.

Patient must be 18 years of age or older.

The Copper Test measures copper levels in blood to evaluate nutritional status, liver function, and metabolic health. Abnormal levels may indicate Wilson’s disease, Menkes disease, liver disorders, or malnutrition. Both deficiency and excess copper can affect nervous system, immune function, and energy metabolism. Doctors use this test to investigate unexplained symptoms, monitor treatment, or assess copper-related disorders, providing key insight into overall health.

The Copper 24 Hour Urine Test evaluates copper elimination in urine across a full day, helping identify metabolic or liver-related disorders. Abnormal levels may signal Wilson’s disease, copper toxicity, or deficiency. By capturing copper output over 24 hours, the test provides insight into copper balance, aiding in the assessment of hepatic function, nutritional status, and the effects of excessive copper exposure.